Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease.

King E, O'Brien J, Donaghy P, Williams-Gray CH, Lawson RA, Morris CM, Barnett N, Olsen K, Martin-Ruiz C, Burn D, Yarnall AJ, Taylor JP, Duncan G, Khoo TK, Thomas A.

Int J Geriatr Psychiatry. 2019 Aug;34(8):1244-1250. doi: 10.1002/gps.5124. Epub 2019 May 16.

PMID:
30993722
2.

Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.

Sleeman I, Lawson RA, Yarnall AJ, Duncan GW, Johnston F, Khoo TK, Burn DJ.

J Parkinsons Dis. 2019;9(2):351-359. doi: 10.3233/JPD-181535.

3.

Respiratory dysfunction in myotonic dystrophy type 1: A systematic review.

Hawkins AM, Hawkins CL, Abdul Razak K, Khoo TK, Tran K, Jackson RV.

Neuromuscul Disord. 2019 Mar;29(3):198-212. doi: 10.1016/j.nmd.2018.12.002. Epub 2018 Dec 9. Review.

PMID:
30765255
4.

Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease.

Durcan R, Wiblin L, Lawson RA, Khoo TK, Yarnall AJ, Duncan GW, Brooks DJ, Pavese N, Burn DJ; ICICLE-PD Study Group.

Eur J Neurol. 2019 Jul;26(7):979-985. doi: 10.1111/ene.13919. Epub 2019 Mar 1.

5.

Ethanol Ablation of Cystic Thyroid Nodules.

Khoo TK.

Mayo Clin Proc. 2019 Jan;94(1):171. doi: 10.1016/j.mayocp.2018.10.004. No abstract available.

PMID:
30611446
6.

Multimorbidity Predicts Quality of Life but not Motor Severity in Early Parkinson's Disease.

Gravell R, Duncan GW, Khoo TK, Burn DJ, Sayer AA, Barker RA, Lawson RA, Yarnall AJ.

J Parkinsons Dis. 2018;8(4):511-515. doi: 10.3233/JPD-181428.

PMID:
30248064
7.

Categorising Visual Hallucinations in Early Parkinson's Disease.

Clegg BJ, Duncan GW, Khoo TK, Barker RA, Burn DJ, Yarnall AJ, Lawson RA.

J Parkinsons Dis. 2018;8(3):447-453. doi: 10.3233/JPD-181338.

PMID:
30040741
8.

Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD study.

Minett T, Su L, Mak E, Williams G, Firbank M, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn D, O'Brien JT.

J Neurol. 2018 Jul;265(7):1528-1539. doi: 10.1007/s00415-018-8873-0. Epub 2018 Apr 25.

PMID:
29696499
9.

Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.

Khoo TK, Olson KM.

N Engl J Med. 2018 Mar 8;378(10):967. doi: 10.1056/NEJMc1800394. No abstract available.

PMID:
29517213
10.

Somatic mutations in salivary duct carcinoma and potential therapeutic targets.

Khoo TK, Yu B, Smith JA, Clarke AJ, Luk PP, Selinger CI, Mahon KL, Kraitsek S, Palme C, Boyer MJ, Dinger ME, Cowley MJ, O'Toole SA, Clark JR, Gupta R.

Oncotarget. 2017 May 25;8(44):75893-75903. doi: 10.18632/oncotarget.18173. eCollection 2017 Sep 29.

11.

Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism.

McLeary FA, Rcom-H'cheo-Gauthier AN, Kinder J, Goulding M, Khoo TK, Mellick GD, Chung RS, Pountney DL.

Neurotox Res. 2018 Feb;33(2):229-238. doi: 10.1007/s12640-017-9825-7. Epub 2017 Oct 24.

PMID:
29064068
12.

The Role of Vitamin D in Disease Progression in Early Parkinson's Disease.

Sleeman I, Aspray T, Lawson R, Coleman S, Duncan G, Khoo TK, Schoenmakers I, Rochester L, Burn D, Yarnall A.

J Parkinsons Dis. 2017;7(4):669-675. doi: 10.3233/JPD-171122.

13.

Bisphosphonates and Osteonecrosis of the Jaw.

Khoo TK.

Mayo Clin Proc. 2017 Jul;92(7):1166-1167. doi: 10.1016/j.mayocp.2017.05.002. No abstract available.

PMID:
28688470
14.

Gait Rather Than Cognition Predicts Decline in Specific Cognitive Domains in Early Parkinson's Disease.

Morris R, Lord S, Lawson RA, Coleman S, Galna B, Duncan GW, Khoo TK, Yarnall AJ, Burn DJ, Rochester L.

J Gerontol A Biol Sci Med Sci. 2017 Nov 9;72(12):1656-1662. doi: 10.1093/gerona/glx071.

15.

Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.

Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Mollenhauer B, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT.

Neurobiol Aging. 2017 Jul;55:78-90. doi: 10.1016/j.neurobiolaging.2017.03.012. Epub 2017 Mar 16.

16.

Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.

Rochester L, Galna B, Lord S, Yarnall AJ, Morris R, Duncan G, Khoo TK, Mollenhauer B, Burn DJ.

Neurology. 2017 Apr 18;88(16):1501-1511. doi: 10.1212/WNL.0000000000003840. Epub 2017 Mar 22. Erratum in: Neurology. 2017 Jul 4;89(1):107.

17.

Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.

Firbank MJ, Yarnall AJ, Lawson RA, Duncan GW, Khoo TK, Petrides GS, O'Brien JT, Barker RA, Maxwell RJ, Brooks DJ, Burn DJ.

J Neurol Neurosurg Psychiatry. 2017 Apr;88(4):310-316. doi: 10.1136/jnnp-2016-313918. Epub 2016 Oct 6.

18.

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.

Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, Barker RA, Burn DJ; ICICLE-PD study group.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):648-652. doi: 10.1136/jnnp-2016-315099. Epub 2017 Mar 1.

19.

Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson's disease.

Dissanayaka NNW, Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Barker RA, Burn DJ; ICICLE-PD study group.

Parkinsonism Relat Disord. 2017 Mar;36:63-68. doi: 10.1016/j.parkreldis.2017.01.001. Epub 2017 Jan 4.

20.

Intra- and inter-network functional alterations in Parkinson's disease with mild cognitive impairment.

Peraza LR, Nesbitt D, Lawson RA, Duncan GW, Yarnall AJ, Khoo TK, Kaiser M, Firbank MJ, O'Brien JT, Barker RA, Brooks DJ, Burn DJ, Taylor JP.

Hum Brain Mapp. 2017 Mar;38(3):1702-1715. doi: 10.1002/hbm.23499. Epub 2017 Jan 13.

PMID:
28084651
21.

Cognitive impairment in Parkinson's disease: impact on quality of life of carers.

Lawson RA, Yarnall AJ, Johnston F, Duncan GW, Khoo TK, Collerton D, Taylor JP, Burn DJ; ICICLE-PD study group.

Int J Geriatr Psychiatry. 2017 Dec;32(12):1362-1370. doi: 10.1002/gps.4623. Epub 2016 Dec 7.

22.

The Impact of Physical Activity on Non-Motor Symptoms in Parkinson's Disease: A Systematic Review.

Cusso ME, Donald KJ, Khoo TK.

Front Med (Lausanne). 2016 Aug 17;3:35. doi: 10.3389/fmed.2016.00035. eCollection 2016. Review.

23.

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention.

Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, Barker RA, Collerton D, Taylor JP, Burn DJ; ICICLE-PD study group.

Parkinsonism Relat Disord. 2016 Jun;27:47-53. doi: 10.1016/j.parkreldis.2016.04.009. Epub 2016 Apr 11.

24.

Factors Affecting Burnout in Physicians.

Khoo TK.

Mayo Clin Proc. 2016 Apr;91(4):536-7. doi: 10.1016/j.mayocp.2016.01.003. No abstract available.

PMID:
27046527
25.

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).

Williams-Gray CH, Wijeyekoon R, Yarnall AJ, Lawson RA, Breen DP, Evans JR, Cummins GA, Duncan GW, Khoo TK, Burn DJ, Barker RA; ICICLE-PD study group.

Mov Disord. 2016 Jul;31(7):995-1003. doi: 10.1002/mds.26563. Epub 2016 Mar 21.

26.

Developing interprofessional education: putting theory into practice.

Teodorczuk A, Khoo TK, Morrissey S, Rogers G.

Clin Teach. 2016 Feb;13(1):7-12. doi: 10.1111/tct.12508. No abstract available.

PMID:
26817749
27.

Anticholinergic Load: Is there a Cognitive Cost in Early Parkinson's Disease?

Yarnall AJ, Lawson RA, Duncan GW, Breen DP, Khoo TK, Brooks D, Barker RA, Taylor JP, Burn DJ.

J Parkinsons Dis. 2015;5(4):743-7. doi: 10.3233/JPD-150664.

PMID:
26444094
28.

Role of cadaveric dissections in modern medical curricula: a study on student perceptions.

Dissabandara LO, Nirthanan SN, Khoo TK, Tedman R.

Anat Cell Biol. 2015 Sep;48(3):205-12. doi: 10.5115/acb.2015.48.3.205. Epub 2015 Sep 22.

29.

Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease?

Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, Brooks DJ, Barker RA, Burn DJ, O'Brien JT.

Mov Disord. 2016 Jan;31(1):103-10. doi: 10.1002/mds.26312. Epub 2015 Jul 22.

PMID:
26202802
30.

Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.

Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, Duncan GW, Owen AM, Khoo TK, Brooks DJ, Rowe JB, Barker RA, Burn DJ, O'Brien JT.

Brain. 2015 Oct;138(Pt 10):2974-86. doi: 10.1093/brain/awv211. Epub 2015 Jul 14.

31.

Preparing to meet the needs of an ageing population - a challenge to medical educators globally.

Tullo E, Khoo TK, Teodorczuk A.

Med Teach. 2015 Feb;37(2):105-7. doi: 10.3109/0142159X.2014.955845. Epub 2014 Sep 3. No abstract available.

PMID:
25182333
32.

Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.

Nombela C, Rowe JB, Winder-Rhodes SE, Hampshire A, Owen AM, Breen DP, Duncan GW, Khoo TK, Yarnall AJ, Firbank MJ, Chinnery PF, Robbins TW, O'Brien JT, Brooks DJ, Burn DJ; ICICLE-PD study group, Barker RA.

Brain. 2014 Oct;137(Pt 10):2743-58. doi: 10.1093/brain/awu201. Epub 2014 Jul 30.

33.

Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life.

Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Barker RA, Collerton D, Taylor JP, Burn DJ.

Parkinsonism Relat Disord. 2014 Oct;20(10):1071-5. doi: 10.1016/j.parkreldis.2014.07.004. Epub 2014 Jul 18.

34.

Quality of life and mild cognitive impairment in early Parkinson's disease: does subtype matter?

Lawson RA, Yarnall AJ, Duncan GW, Khoo TK, Breen DP, Barker RA, Collerton D, Taylor JP, Burn DJ.

J Parkinsons Dis. 2014;4(3):331-6. doi: 10.3233/JPD-140390.

PMID:
24919824
35.

Primary sleep disorder prevalence in patients with newly diagnosed Parkinson’s disease.

Prudon B, Duncan GW, Khoo TK, Yarnall AJ, Anderson KN.

Mov Disord. 2014 Feb;29(2):259-62.

PMID:
24464648
36.

Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study.

Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O'Brien JT, Robbins TW, Wesnes K, Brooks DJ, Barker RA, Burn DJ; ICICLE-PD Study Group.

Neurology. 2014 Jan 28;82(4):308-16. doi: 10.1212/WNL.0000000000000066. Epub 2013 Dec 20.

37.

Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms.

Duncan GW, Khoo TK, Yarnall AJ, O'Brien JT, Coleman SY, Brooks DJ, Barker RA, Burn DJ.

Mov Disord. 2014 Feb;29(2):195-202. doi: 10.1002/mds.25664. Epub 2013 Oct 7.

PMID:
24123307
38.

The incidence of Parkinson's disease in the North-East of England.

Duncan GW, Khoo TK, Coleman SY, Brayne C, Yarnall AJ, O'Brien JT, Barker RA, Burn DJ.

Age Ageing. 2014 Mar;43(2):257-63. doi: 10.1093/ageing/aft091. Epub 2013 Jul 23.

PMID:
23880142
39.

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.

UKMND-LiCALS Study Group, Morrison KE, Dhariwal S, Hornabrook R, Savage L, Burn DJ, Khoo TK, Kelly J, Murphy CL, Al-Chalabi A, Dougherty A, Leigh PN, Wijesekera L, Thornhill M, Ellis CM, O'Hanlon K, Panicker J, Pate L, Ray P, Wyatt L, Young CA, Copeland L, Ealing J, Hamdalla H, Leroi I, Murphy C, O'Keeffe F, Oughton E, Partington L, Paterson P, Rog D, Sathish A, Sexton D, Smith J, Vanek H, Dodds S, Williams TL, Steen IN, Clarke J, Eziefula C, Howard R, Orrell R, Sidle K, Sylvester R, Barrett W, Merritt C, Talbot K, Turner MR, Whatley C, Williams C, Williams J, Cosby C, Hanemann CO, Iman I, Philips C, Timings L, Crawford SE, Hewamadduma C, Hibberd R, Hollinger H, McDermott C, Mils G, Rafiq M, Shaw PJ, Taylor A, Waines E, Walsh T, Addison-Jones R, Birt J, Hare M, Majid T.

Lancet Neurol. 2013 Apr;12(4):339-45. doi: 10.1016/S1474-4422(13)70037-1. Epub 2013 Feb 27. Erratum in: Lancet Neurol. 2013 Sep;12(9):846.

40.

Rapid eye movement sleep behavior disorder in Parkinson's disease: magnetic resonance imaging study.

Ford AH, Duncan GW, Firbank MJ, Yarnall AJ, Khoo TK, Burn DJ, O'Brien JT.

Mov Disord. 2013 Jun;28(6):832-6. doi: 10.1002/mds.25367. Epub 2013 Feb 28.

PMID:
23450684
41.

Short latency afferent inhibition: a biomarker for mild cognitive impairment in Parkinson's disease?

Yarnall AJ, Rochester L, Baker MR, David R, Khoo TK, Duncan GW, Galna B, Burn DJ.

Mov Disord. 2013 Aug;28(9):1285-8. doi: 10.1002/mds.25360. Epub 2013 Feb 28.

PMID:
23450646
42.
43.

The spectrum of nonmotor symptoms in early Parkinson disease.

Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O'Brien JT, Brooks DJ, Barker RA, Burn DJ.

Neurology. 2013 Jan 15;80(3):276-81. doi: 10.1212/WNL.0b013e31827deb74.

44.

Purification of recombinant antigen BmSXP used in panLF rapid kit for lymphatic filariasis.

Khoo TK, Noordin R, Santhanam A.

Indian J Exp Biol. 2012 Apr;50(4):256-64.

PMID:
22611913
45.

Impaired fasting plasma glucose and stroke risk.

Khoo TK.

Mayo Clin Proc. 2012 Feb;87(2):209; author reply 209-10. doi: 10.1016/j.mayocp.2011.11.010. No abstract available.

46.

Falling short: underestimation of fracture risk in atypical parkinsonian syndromes.

Yarnall AJ, Duncan GW, Khoo TK, Burn DJ.

Parkinsonism Relat Disord. 2012 Jun;18(5):692-3. doi: 10.1016/j.parkreldis.2012.01.004. Epub 2012 Jan 20. No abstract available.

PMID:
22265139
47.

Parkin inactivation via PARIS (ZNF746) may lead to neurodegeneration in Parkinson's disease.

Khoo TK.

Mov Disord. 2011 Apr;26(5):772. No abstract available.

PMID:
21671509
48.

Adverse events associated with testosterone administration.

Khoo TK.

N Engl J Med. 2010 Nov 4;363(19):1865-6; author reply 1866-7. doi: 10.1056/NEJMc1009326. No abstract available.

PMID:
21047235
49.

Non-motor symptoms may herald Parkinson's disease.

Khoo TK, Burn DJ.

Practitioner. 2009 Sep;253(1721):19-24, 2.

PMID:
19873855
50.

Glucose control in critically ill patients.

Khoo TK, Olsen KA.

N Engl J Med. 2009 Jul 2;361(1):90; author reply 91-2. No abstract available.

PMID:
19579274

Supplemental Content

Support Center